Vera Ghali: 2026 ASH–ISTH Recommendations on Pediatric VTE Prevention
Vera Ghali, Member of the Lebanese Order of Physicians and Lebanese Pediatric Society, shared Blood Journals Portfolio‘s post on X:
“The 2026 ASH-ISTH guidelines and recommendations on anti-coagulant prophylaxis for pediatric patients at risk of Venous Thromboembolism (VTE).
The panel underscores the necessity to individualize anti-coagulant prophylaxis for pVTE and resorting to careful assessment of each child’s thrombotic and bleeding risks, with special attention to children’s specificities across different subgroups.
The panel highlights that children with leukemia and lymphoblastic lymphoma (LBL) who benefit the most from anticoagulation are those who are older than 10 years, those with obesity, T-cell immunophenotype, high-risk Acute Lymphoblastic Leukemia (ALL), and children with a personal or family history of thrombosis.
Factors that increase bleeding with anticoagulant prophylaxis are: younger age, severe thrombocytopenia, renal dysfunction, and previous bleeding.
Furthermore, asparaginase is a severe pro-thrombotic agent, consequently, anticoagulation should be initiated during asparaginase-containing chemotherapy cycles and discontinued as soon as the asparaginase hypercoagulable effects wear off.”
Blood Journals Portfolio shared a post on X about a recent article by Marisol Betensky et al., published in Blood:
“New in Blood Advances: ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism.”
Title: ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism
Authors: Marisol Betensky, Muayad Azzam, Rachel Bercovitz, Rukhmi V Bhat, Tina Biss, Brian Branchford, Leonardo R Brandão, Anthony K C Chan, E Vincent S Faustino, Qais Hamarsha, Julie Jaffray, Sophie Jones, Hassan Kawtharany, Bryce A Kerlin, Jana Khawandi, Grace Krider, Nicole Kucine, Riten Kumar, Christoph Male, Paul Monagle, Marie-Claude Pelland-Marcotte, Leslie Raffini, Chittalsinh Raulji, Sarah E Sartain, Clifford M Takemoto, Cristina Tarango, C Heleen van Ommen, Maria C Velez, Sara K Vesely, John Wiernikowski, Suzan Williams, Hope P Wilson, Gary Woods, Reem A Mustafa
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 12, 2026, 15:00Kavya Sruthi: Clinical Practice Guideline for Anemia Management in Chronic Kidney Disease
-
Aug 12, 2026, 10:58Raed Ahmed: New Insights into Severe Vaso-Occlusive Crisis in Pediatric Sickle Cell Disease
-
Aug 12, 2026, 10:27Cliff Oguk: Designing Health AI Around Real-World Clinical Needs
-
Aug 12, 2026, 09:51Orlando Agrippa: Why Promising Sickle Cell Therapies Continue to Fall Short
-
Aug 12, 2026, 09:34Tiffany Hall: Why Hemoglobin Alone Is Not Enough Before Cardiac Surgery
-
Aug 12, 2026, 08:33Craig Clapper: What the Andrea Doria Collision Teaches Us About Safety
-
Aug 12, 2026, 08:16Chengyong Yang: Can Plasma Reveal Cell Specific Signals
-
Aug 12, 2026, 07:49Alan Dursun: Phnom Penh, Cambodia – Part 3 – Turning Partnership into Action
-
Aug 12, 2026, 06:55Alejandro González Veliz: A Good PCI is not Just about Opening the Artery